At Kaneka Probiotics, we’re committed to advancing the science of probiotics with clinically validated solutions that deliver measurable results. We’re excited to share that a new clinical trial on KABP® 50+ has been published in the peer-reviewed Journal of Dietary Supplements.
The randomized, double-blind, placebo-controlled study followed 70 healthy adults between the ages of 50 and 85 who experienced occasional constipation. Over the course of 84 days, participants received either KABP® 50+ or a placebo, allowing researchers to carefully evaluate both digestive and emotional outcomes.
The results showed that KABP® 50+ provides meaningful support for healthy aging, with benefits extending beyond digestive comfort into overall quality of life.
Key Findings from the Study
- Bowel Regularity & Stool Consistency – Participants taking KABP® 50+ experienced statistically significant improvements in both frequency and consistency of bowel movements.
- Reduced Perceived Stress – Beyond digestive health, participants reported lower levels of stress, pointing to the gut-brain connection and the formula’s role in supporting emotional balance.
- Safe & Well-Tolerated – Importantly, KABP® 50+ was shown to be safe and well-tolerated in this healthy aging population, underscoring its suitability for long-term use.
Why It Matters for Brands
Today’s consumers—especially those over 50—are seeking targeted, science-backed solutions that go beyond “general gut health.” This study reinforces the value of precision probiotics in delivering differentiated, clinically validated benefits. With aging populations prioritizing both digestive comfort and emotional well-being, KABP® 50+ represents a powerful ingredient to help brands create products that truly stand out.
At Kaneka Probiotics, we continue to invest in research that builds trust, demonstrates efficacy, and expands what probiotics can do for human health. This publication is another step forward in our mission to make advanced probiotic science a reality for brands and the consumers they serve.
Interested in adding KABP® 50+ to your product portfolio? Contact our team today to explore how Kaneka Probiotics can help you deliver differentiated, clinically validated solutions.